לקסיבה

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

FOSAMPRENAVIR AS FOSAMPRENAVIR CALCIUM 700 MG

Dostupno od:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC koda:

J05AE07

Farmaceutski oblik:

TABLETS

Administracija rute:

PER OS

Proizveden od:

GLAXO WELLCOME SA, SPAIN

Terapijska grupa:

FOSAMPRENAVIR

Terapijske indikacije:

Lexiva is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. The following points should be considered when initiating therapy with Lexiva/ritonavir in protease inhibitor - experienced patients: - The protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that Lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - Once - daily administration of Lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Datum autorizacije:

2012-01-01